In conclusion, while submitting the SmPC as part of the MAA is a requirement for biotech companies, publicly disclosing the receipt of the SmPC from the MHRA during the review process does not appear to be a specific regulatory obligation according to the provided search results. Apply for a licence to market a medicine in the UK - GOV.UK